NIVESTYM Trademark

Trademark Overview

On Monday, February 22, 2016, a trademark application was filed for NIVESTYM with the United States Patent and Trademark Office. The USPTO has given the NIVESTYM trademark a serial number of 86914849. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2019. This trademark is owned by Hospira, Inc.. The NIVESTYM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for stimulating white blood cell production
nivestym

General Information

Serial Number86914849
Word MarkNIVESTYM
Filing DateMonday, February 22, 2016
Status700 - REGISTERED
Status DateTuesday, April 9, 2019
Registration Number5722625
Registration DateTuesday, April 9, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 26, 2016
Primary Code005
First Use Anywhere DateMonday, October 1, 2018
First Use In Commerce DateMonday, October 1, 2018

Trademark Owner History

Party NameHospira, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameHospira, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameHospira, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045

Trademark Events

Event DateEvent Description
Tuesday, April 9, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 9, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 5, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 4, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 19, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, January 28, 2019USE AMENDMENT FILED
Tuesday, February 19, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 28, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, September 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 2, 2018SOU EXTENSION 4 GRANTED
Sunday, September 2, 2018SOU EXTENSION 4 FILED
Sunday, September 2, 2018SOU TEAS EXTENSION RECEIVED
Friday, February 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2018SOU EXTENSION 3 GRANTED
Wednesday, February 14, 2018SOU EXTENSION 3 FILED
Wednesday, February 14, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, August 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2017SOU EXTENSION 2 GRANTED
Monday, July 31, 2017SOU EXTENSION 2 FILED
Monday, July 31, 2017SOU TEAS EXTENSION RECEIVED
Saturday, March 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 2, 2017SOU EXTENSION 1 GRANTED
Thursday, March 2, 2017SOU EXTENSION 1 FILED
Thursday, March 2, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, September 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 7, 2016ASSIGNED TO EXAMINER
Friday, February 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 25, 2016NEW APPLICATION ENTERED

Related Keywords

nivestym cell production blood white preparations stimulating pharmaceutical